Calix weakness a buying opportunity, says Cowen Cowen would use the weakness in Calix following disappointing guidance as a buying opportunity. The firm views the weakness as transitory and the long term outlook unchanged. Shares remain Outperform rated but price target lowered to $11 from $14.
News For CALX From The Last 14 Days
Check below for free stories on CALX the last two weeks.